An innovation arm's performance isn't its "batting average." If a team pursues truly ambitious, "exotic" opportunities, a high failure rate is an expected and even positive signal. An overly high success rate suggests the team is only taking safe, incremental bets, defeating its purpose.

The worst feeling for an investor is not missing a successful deal they didn't understand, but investing against their own judgment in a company that ultimately fails. This emotional cost of violating one's own conviction outweighs the FOMO of passing on a hot deal.

Even with big wins, a venture portfolio can fail if not constructed properly. The relative size of your investments is often more critical than picking individual winners, as correctly sized successful investments must be large enough to overcome the inevitable losers in the portfolio.

In venture capital, the potential return from a single massive winner (1000x) is so asymmetric that it dwarfs the cost of multiple failures (1x loss). This reality dictates that the primary focus should be on identifying and capturing huge winners, making the failure to invest in one a far greater error than investing in a company that goes to zero.

Investors who lose money in a sector develop an emotional aversion, causing them to irrationally pass on the next great company in that space. This 'learning from mistakes' becomes a liability, prioritizing avoiding small losses (commission) over capturing huge wins (omission).

The financial loss from a failed startup investment is capped at 1x the capital. Conversely, the opportunity cost of passing on a company that becomes worth billions is uncapped and unlimited. This asymmetry dictates that VCs should fear sins of omission more than sins of commission.

A successful early-stage strategy involves actively maximizing specific risks—product, market, and timing—to pursue transformative ideas. Conversely, risks related to capital efficiency and team quality should be minimized. This framework pushes a firm to take big, non-obvious swings instead of settling for safer, incremental bets.

Sequoia's internal philosophy dictates that venture capital is not a downside minimization game. A fund with a write-off rate below 40% is seen as not taking enough risk to generate outlier returns. This counter-intuitive metric prioritizes bold bets over preserving capital on every deal.

Alex Rubalcava reveals that the most valuable advice he gives founders comes directly from past mistakes in his portfolio that cost millions of dollars. This "scar tissue" provides a hard-won perspective on what not to do—insights that are impossible to gain from successes alone.